Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma.

Siebert C, Ciato D, Murakami M, Frei-Stuber L, Perez-Rivas LG, Monteserin-Garcia JL, Nölting S, Maurer J, Feuchtinger A, Walch AK, Haak HR, Bertherat J, Mannelli M, Fassnacht M, Korpershoek E, Reincke M, Stalla GK, Hantel C, Beuschlein F.

Front Endocrinol (Lausanne). 2019 Jul 19;10:487. doi: 10.3389/fendo.2019.00487. eCollection 2019.

2.

Strengths and weaknesses of the acute care systems in the United Kingdom and the Netherlands: what can we learn from each other?

Kremers MNT, Nanayakkara PWB, Levi M, Bell D, Haak HR.

BMC Emerg Med. 2019 Jul 26;19(1):40. doi: 10.1186/s12873-019-0257-y.

3.

Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study.

Berruti A, Libè R, Laganà M, Ettaieb H, Sukkari MA, Bertherat J, Feelders RA, Grisanti S, Cartry J, Mazziotti G, Sigala S, Baudin E, Haak H, Habra MA, Terzolo M.

Eur J Endocrinol. 2019 May 1;180(5):311-320. doi: 10.1530/EJE-19-0026.

PMID:
30970324
4.

No age thresholds in the emergency department: A retrospective cohort study on age differences.

Fuchs C, Çelik B, Brouns SHA, Kaymak U, Haak HR.

PLoS One. 2019 Jan 30;14(1):e0210743. doi: 10.1371/journal.pone.0210743. eCollection 2019.

5.

Performance of the Manchester triage system in older emergency department patients: a retrospective cohort study.

Brouns SHA, Mignot-Evers L, Derkx F, Lambooij SL, Dieleman JP, Haak HR.

BMC Emerg Med. 2019 Jan 7;19(1):3. doi: 10.1186/s12873-018-0217-y.

6.

Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start.

Stelten BML, Huidekoper HH, van de Warrenburg BPC, Brilstra EH, Hollak CEM, Haak HR, Kluijtmans LAJ, Wevers RA, Verrips A.

Neurology. 2019 Jan 8;92(2):e83-e95. doi: 10.1212/WNL.0000000000006731. Epub 2018 Dec 7.

PMID:
30530799
7.

European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

Fassnacht M, Dekkers OM, Else T, Baudin E, Berruti A, de Krijger R, Haak HR, Mihai R, Assie G, Terzolo M.

Eur J Endocrinol. 2018 Oct 1;179(4):G1-G46. doi: 10.1530/EJE-18-0608.

PMID:
30299884
8.

When patients' invisible work becomes visible: non-adherence and the routine task of pill-taking.

Huyard C, Haak H, Derijks L, Lieverse L.

Sociol Health Illn. 2019 Jan;41(1):5-19. doi: 10.1111/1467-9566.12806. Epub 2018 Sep 16.

PMID:
30221385
9.

European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors.

Fassnacht M, Dekkers O, Else T, Baudin E, Berruti A, de Krijger RR, Haak HR, Mihai R, Assie G, Terzolo M.

Eur J Endocrinol. 2018 Jul 24. pii: EJE-18-0608. doi: 10.1530/EJE-18-0608. [Epub ahead of print]

PMID:
30042120
10.

Quality and Quantity of Sleep and Factors Associated With Sleep Disturbance in Hospitalized Patients.

Wesselius HM, van den Ende ES, Alsma J, Ter Maaten JC, Schuit SCE, Stassen PM, de Vries OJ, Kaasjager KHAH, Haak HR, van Doormaal FF, Hoogerwerf JJ, Terwee CB, van de Ven PM, Bosch FH, van Someren EJW, Nanayakkara PWB; “Onderzoeks Consortium Acute Geneeskunde” Acute Medicine Research Consortium.

JAMA Intern Med. 2018 Sep 1;178(9):1201-1208. doi: 10.1001/jamainternmed.2018.2669.

11.

Unplanned readmissions among patients presenting with nonspecific complaints.

Wachelder JJH, van Galen LS, Kellett J, Nickel CH, Haak HR; safer@home consortium.

Eur J Intern Med. 2018 Aug;54:e36-e37. doi: 10.1016/j.ejim.2018.05.020. Epub 2018 Jun 7. No abstract available.

PMID:
29885755
12.

Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK.

de Jong RGPJ, Peeters PJHL, Burden AM, de Bruin ML, Haak HR, Masclee AAM, de Vries F, Janssen-Heijnen MLG.

Cancer Epidemiol. 2018 Jun;54:104-111. doi: 10.1016/j.canep.2018.04.008. Epub 2018 May 16.

PMID:
29705628
13.

Outcome of elderly emergency department patients hospitalised on weekends - a retrospective cohort study.

Brouns SHA, Wachelder JJ, Jonkers FS, Lambooij SL, Dieleman JP, Haak HR.

BMC Emerg Med. 2018 Mar 7;18(1):9. doi: 10.1186/s12873-018-0160-y.

14.

Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study.

Buitenwerf E, Korteweg T, Visser A, Haag CMSC, Feelders RA, Timmers HJLM, Canu L, Haak HR, Bisschop PHLT, Eekhoff EMW, Corssmit EPM, Krak NC, Rasenberg E, van den Bergh J, Stoker J, Greuter MJW, Dullaart RPF, Links TP, Kerstens MN.

Eur J Endocrinol. 2018 May;178(5):431-437. doi: 10.1530/EJE-18-0006. Epub 2018 Feb 21.

PMID:
29467230
15.

Association of socioeconomic status with outcomes in older adult community-dwelling patients after visiting the emergency department: a retrospective cohort study.

Wachelder JJH, van Drunen I, Stassen PM, Brouns SHA, Lambooij SLE, Aarts MJ, Haak HR.

BMJ Open. 2017 Dec 26;7(12):e019318. doi: 10.1136/bmjopen-2017-019318.

16.

Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial.

Alam N, Oskam E, Stassen PM, Exter PV, van de Ven PM, Haak HR, Holleman F, Zanten AV, Leeuwen-Nguyen HV, Bon V, Duineveld BAM, Nannan Panday RS, Kramer MHH, Nanayakkara PWB; PHANTASi Trial Investigators and the ORCA (Onderzoeks Consortium Acute Geneeskunde) Research Consortium the Netherlands.

Lancet Respir Med. 2018 Jan;6(1):40-50. doi: 10.1016/S2213-2600(17)30469-1. Epub 2017 Nov 28.

PMID:
29196046
17.

Elderly emergency patients presenting with non-specific complaints: Characteristics and outcomes.

Wachelder JJH, Stassen PM, Hubens LPAM, Brouns SHA, Lambooij SLE, Dieleman JP, Haak HR.

PLoS One. 2017 Nov 30;12(11):e0188954. doi: 10.1371/journal.pone.0188954. eCollection 2017.

18.

Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes.

Zanders MMJ, Haak HR, van Herk-Sukel MPP, Herings RMC, van de Poll-Franse LV, Johnson JA.

Diabetes Metab. 2018 Feb;44(1):22-29. doi: 10.1016/j.diabet.2017.08.004. Epub 2017 Oct 22.

PMID:
29066209
19.

Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.

Sbiera S, Sbiera I, Ruggiero C, Doghman-Bouguerra M, Korpershoek E, de Krijger RR, Ettaieb H, Haak H, Volante M, Papotti M, Reimondo G, Terzolo M, Luconi M, Nesi G, Mannelli M, Libé R, Ragazzon B, Assié G, Bertherat J, Altieri B, Fadda G, Rogowski-Lehmann N, Reincke M, Beuschlein F, Fassnacht M, Lalli E.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3491-3498. doi: 10.1210/jc.2017-00984.

20.

Identifying User Preferences for a Digital Educational Solution for Young Seniors With Diabetes.

van der Molen P, Maas AH, Chen W, van Pul C, Cottaar EJE, van Riel NAW, Hilbers PAJ, Haak HR.

Diabetes Spectr. 2017 Aug;30(3):182-187. doi: 10.2337/ds16-0023.

21.

Intentional Nonadherence as a Means to Exert Control.

Huyard C, Derijks L, Haak H, Lieverse L.

Qual Health Res. 2017 Jul;27(8):1215-1224. doi: 10.1177/1049732316688882. Epub 2017 Jan 25.

PMID:
28682739
22.

Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes.

van Herpt TTW, Lemmers RFH, van Hoek M, Langendonk JG, Erdtsieck RJ, Bravenboer B, Lucas A, Mulder MT, Haak HR, Lieverse AG, Sijbrands EJG.

Diabetol Metab Syndr. 2017 Jun 19;9:47. doi: 10.1186/s13098-017-0245-x. eCollection 2017.

23.

Patients' and providers' perceptions of the preventability of hospital readmission: a prospective, observational study in four European countries.

van Galen LS, Brabrand M, Cooksley T, van de Ven PM, Merten H, So RK, van Hooff L, Haak HR, Kidney RM, Nickel CH, Soong JT, Weichert I, Kramer MH, Subbe CP, Nanayakkara PW; Safer@home consortium.

BMJ Qual Saf. 2017 Dec;26(12):958-969. doi: 10.1136/bmjqs-2017-006645. Epub 2017 Jun 22.

PMID:
28642333
24.

Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus.

de Jong RGPJ, Burden AM, de Kort S, van Herk-Sukel MPP, Vissers PAJ, Janssen PKC, Haak HR, Masclee AAM, de Vries F, Janssen-Heijnen MLG.

Eur J Cancer. 2017 Jul;79:61-71. doi: 10.1016/j.ejca.2017.03.039. Epub 2017 Apr 29.

PMID:
28463757
25.

Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation.

de Kort S, Masclee AAM, Sanduleanu S, Weijenberg MP, van Herk-Sukel MPP, Oldenhof NJJ, van den Bergh JPW, Haak HR, Janssen-Heijnen ML.

Sci Rep. 2017 Apr 24;7:46527. doi: 10.1038/srep46527.

26.

Applicability of the modified Emergency Department Work Index (mEDWIN) at a Dutch emergency department.

Brouns SH, van der Schuit KC, Stassen PM, Lambooij SL, Dieleman J, Vanderfeesten IT, Haak HR.

PLoS One. 2017 Mar 10;12(3):e0173387. doi: 10.1371/journal.pone.0173387. eCollection 2017.

27.

No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure.

de Jong RG, Burden AM, de Kort S, van Herk-Sukel MP, Vissers PA, Janssen PK, Haak HR, Masclee AA, de Vries F, Janssen-Heijnen ML.

Cancer Prev Res (Phila). 2017 May;10(5):290-297. doi: 10.1158/1940-6207.CAPR-16-0277. Epub 2017 Mar 8.

28.

Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.

Madani A, Thomassen I, van Gestel YRBM, van der Bilt JDW, Haak HR, de Hingh IHJT, Lemmens VEPP.

Ann Surg Oncol. 2017 Aug;24(8):2199-2205. doi: 10.1245/s10434-016-5734-x. Epub 2017 Feb 15.

PMID:
28204963
29.

Dietary nitrate does not reduce oxygen cost of exercise or improve muscle mitochondrial function in patients with mitochondrial myopathy.

Nabben M, Schmitz JPJ, Ciapaite J, le Clercq CMP, van Riel NA, Haak HR, Nicolay K, de Coo IFM, Smeets H, Praet SF, van Loon LJ, Prompers JJ.

Am J Physiol Regul Integr Comp Physiol. 2017 May 1;312(5):R689-R701. doi: 10.1152/ajpregu.00264.2016. Epub 2017 Feb 8.

30.

The Power of Flash Mob Research: Conducting a Nationwide Observational Clinical Study on Capillary Refill Time in a Single Day.

Alsma J, van Saase JLCM, Nanayakkara PWB, Schouten WEMI, Baten A, Bauer MP, Holleman F, Ligtenberg JJM, Stassen PM, Kaasjager KHAH, Haak HR, Bosch FH, Schuit SCE; FAMOUS Study Group*.

Chest. 2017 May;151(5):1106-1113. doi: 10.1016/j.chest.2016.11.035. Epub 2016 Dec 7.

PMID:
27940191
31.

Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal Network.

Ettaieb MH, Duker JC, Feelders RA, Corssmit EP, Menke-van der Houven van Oordt CW, Timmers HJ, Kerstens MN, Wilmink JW, Zelissen PM, Havekes B, Haak HR.

Horm Cancer. 2016 Dec;7(5-6):336-344. Epub 2016 Jul 15.

PMID:
27422613
32.

Impact of cancer diagnosis and treatment on glycaemic control among individuals with colorectal cancer using glucose-lowering drugs.

Zanders MM, van Herk-Sukel MP, Herings RM, van de Poll-Franse LV, Haak HR.

Acta Diabetol. 2016 Oct;53(5):727-35. doi: 10.1007/s00592-016-0863-z. Epub 2016 Apr 18.

PMID:
27087004
33.

Concept Development of the Eindhoven Diabetes Education Simulator Project.

Maas AH, van der Molen P, van de Vijver R, Chen W, van Pul C, Cottaar EJ, van Riel NA, Hilbers PA, Haak HR.

Games Health J. 2016 Apr;5(2):120-7. doi: 10.1089/g4h.2015.0037. Epub 2016 Feb 12.

PMID:
26871654
34.

Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.

Libé R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O, Bala M, Tabarin A, Beuschlein F, Vezzosi D, Deutschbein T, Borson-Chazot F, Hermsen I, Stell A, Fottner C, Leboulleux S, Hahner S, Mannelli M, Berruti A, Haak H, Terzolo M, Fassnacht M, Baudin E; ENSAT network.

Ann Oncol. 2015 Oct;26(10):2119-25. doi: 10.1093/annonc/mdv329.

35.

Organisational Factors Induce Prolonged Emergency Department Length of Stay in Elderly Patients--A Retrospective Cohort Study.

Brouns SH, Stassen PM, Lambooij SL, Dieleman J, Vanderfeesten IT, Haak HR.

PLoS One. 2015 Aug 12;10(8):e0135066. doi: 10.1371/journal.pone.0135066. eCollection 2015.

36.

Developing treatment for adrenocortical carcinoma.

Kerkhofs TM, Ettaieb MH, Hermsen IG, Haak HR.

Endocr Relat Cancer. 2015 Dec;22(6):R325-38. doi: 10.1530/ERC-15-0318. Epub 2015 Aug 10. Review.

PMID:
26259571
37.

Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?

Zanders MM, van Herk-Sukel MP, Vissers PA, Herings RM, Haak HR, van de Poll-Franse LV.

Br J Cancer. 2015 Jul 28;113(3):403-10. doi: 10.1038/bjc.2015.259. Epub 2015 Jul 16.

38.

Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors.

Kerkhofs TM, Kerstens MN, Kema IP, Willems TP, Haak HR.

Horm Cancer. 2015 Aug;6(4):168-75. doi: 10.1007/s12672-015-0224-3. Epub 2015 May 19.

39.

A new Stark decelerator based surface scattering instrument for studying energy transfer at the gas-surface interface.

Engelhart DP, Grätz F, Wagner RJ, Haak H, Meijer G, Wodtke AM, Schäfer T.

Rev Sci Instrum. 2015 Apr;86(4):043306. doi: 10.1063/1.4918797.

PMID:
25933854
40.

Adrenal tumors with unexpected outcome: a review of the literature.

Kerkhofs TM, Roumen RM, Demeyere TB, van der Linden AN, Haak HR.

Int J Endocrinol. 2015;2015:710514. doi: 10.1155/2015/710514. Epub 2015 Mar 25. Review.

41.

Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms. Reply to Pouwer F [letter].

Zanders MM, Haak HR, van Herk-Sukel MP, van de Poll-Franse LV, Johnson JA.

Diabetologia. 2015 Jun;58(6):1380-1. doi: 10.1007/s00125-015-3578-8. Epub 2015 Apr 3. No abstract available.

PMID:
25835727
42.

Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study.

Fassnacht M, Berruti A, Baudin E, Demeure MJ, Gilbert J, Haak H, Kroiss M, Quinn DI, Hesseltine E, Ronchi CL, Terzolo M, Choueiri TK, Poondru S, Fleege T, Rorig R, Chen J, Stephens AW, Worden F, Hammer GD.

Lancet Oncol. 2015 Apr;16(4):426-35. doi: 10.1016/S1470-2045(15)70081-1. Epub 2015 Mar 18.

43.

Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes.

Zanders MM, Haak HR, van Herk-Sukel MP, van de Poll-Franse LV, Johnson JA.

Diabetologia. 2015 May;58(5):951-60. doi: 10.1007/s00125-015-3497-8. Epub 2015 Feb 1.

PMID:
25638246
44.

Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.

Beuschlein F, Weigel J, Saeger W, Kroiss M, Wild V, Daffara F, Libé R, Ardito A, Al Ghuzlan A, Quinkler M, Oßwald A, Ronchi CL, de Krijger R, Feelders RA, Waldmann J, Willenberg HS, Deutschbein T, Stell A, Reincke M, Papotti M, Baudin E, Tissier F, Haak HR, Loli P, Terzolo M, Allolio B, Müller HH, Fassnacht M.

J Clin Endocrinol Metab. 2015 Mar;100(3):841-9. doi: 10.1210/jc.2014-3182. Epub 2015 Jan 5.

45.

A physiology-based model describing heterogeneity in glucose metabolism: the core of the Eindhoven Diabetes Education Simulator (E-DES).

Maas AH, Rozendaal YJ, van Pul C, Hilbers PA, Cottaar WJ, Haak HR, van Riel NA.

J Diabetes Sci Technol. 2015 Mar;9(2):282-92. doi: 10.1177/1932296814562607. Epub 2014 Dec 18.

46.

Hyponatraemia in elderly emergency department patients: a marker of frailty.

Brouns SH, Dortmans MK, Jonkers FS, Lambooij SL, Kuijper A, Haak HR.

Neth J Med. 2014 Jul;72(6):311-7.

47.

Adrenocortical carcinoma in children: first population-based clinicopathological study with long-term follow-up.

Kerkhofs TM, Ettaieb MH, Verhoeven RH, Kaspers GJ, Tissing WJ, Loeffen J, Van den Heuvel-Eibrink MM, De Krijger RR, Haak HR.

Oncol Rep. 2014 Dec;32(6):2836-44. doi: 10.3892/or.2014.3506. Epub 2014 Sep 22.

PMID:
25241764
48.

Short-term variation in plasma mitotane levels confirms the importance of trough level monitoring.

Kerkhofs TM, Derijks LJ, Ettaieb MH, Eekhoff EM, Neef C, Gelderblom H, den Hartigh J, Guchelaar HJ, Haak HR.

Eur J Endocrinol. 2014 Dec;171(6):677-83. doi: 10.1530/EJE-14-0388. Epub 2014 Sep 8.

PMID:
25201518
49.

Development of a pharmacokinetic model of mitotane: toward personalized dosing in adrenocortical carcinoma.

Kerkhofs TM, Derijks LJ, Ettaieb H, den Hartigh J, Neef K, Gelderblom H, Guchelaar HJ, Haak HR.

Ther Drug Monit. 2015 Feb;37(1):58-65. doi: 10.1097/FTD.0000000000000102.

PMID:
24887633
50.

Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravis.

Hermans MA, Stelten BM, Haak HR, de Herder WW, Dercksen MW.

Endocrinol Diabetes Metab Case Rep. 2014;2014:140013. doi: 10.1530/EDM-14-0013. Epub 2014 May 1.

Supplemental Content

Support Center